Because TNFα is a pleiotropic cytokine with several immunological roles [26], the inhibition of TNFα mediated by sTNFR-1 may suppress the antitumor activity of ICIs in patients with RCC. The gene discussed is TNF; the disease is renal cell carcinoma.